Belluscura (BELL)

Sector:

Health Care

Index:

FTSE AIM All-Share

7.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 50.00
  • 52 Week Low: 7.00
  • Currency: UK Pounds
  • Shares Issued: 165.03m
  • Volume: 454,931
  • Market Cap: £11.96m

Belluscura Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -526.8% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 9.7 n/a
Pr/Book 0.7  
Latest F'cast
Revenue 267.1% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Belluscura Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (1.98) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.42 (5.21) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 1.54 (8.15) (6.80)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Belluscura Company Announcements

Belluscura Concert Party 17-Apr-2024 07:00 RNS
Holding(s) in Company 11-Apr-2024 10:23 RNS
Holding(s) in Company 08-Apr-2024 13:15 RNS

Belluscura ShareCast News

Belluscura enters partnership with Sunset Health... 13-Feb-2024 ShareCast
Belluscura bid for TMT Acquisition goes uncondit... 09-Feb-2024 ShareCast
Belluscura confident in outlook after getting Ch... 20-Dec-2023 ShareCast

Latest Belluscura Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Belluscura Market Data

Currency UK Pounds
Share Price 7.25p
Change Today -0.50p
% Change -6.45 %
52 Week High 50.00
52 Week Low 7.00
Volume 454,931
Shares Issued 165.03m
Market Cap £11.96m

Belluscura Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.18% above the market average45.18% above the market average45.18% above the market average45.18% above the market average45.18% above the market average
41.94% above the sector average41.94% above the sector average41.94% above the sector average41.94% above the sector average41.94% above the sector average
Price Trend
97.24% below the market average97.24% below the market average97.24% below the market average97.24% below the market average97.24% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
22.30% above the market average22.30% above the market average22.30% above the market average22.30% above the market average22.30% above the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average

Belluscura Dividends

No dividends found

Trades for 30-Apr-2024

Time Volume / Share Price
16:39 5,000 @ 7.50p
16:11 132,014 @ 7.05p
16:10 100,000 @ 7.00p
16:09 5,000 @ 7.01p
16:08 10,000 @ 7.00p

Belluscura Key Personnel

CEO Robert “Bob” Rauker
CFO Simon Neicheril

Top of Page